Soybean Oil (ZL janvier 2026)/ ECBOT
ZL24/05/2024 00:00:00 | Chg. -0.6400 | Ouverture | Haut | Bas | Précédent Fermer |
---|---|---|---|---|---|
45.3900USD | -1.39% | 45.3900 | 45.3900 | 45.3900 | 46.0300 |
GlobeNewswire
13:32
WIDEOPENWEST ALERT: WideOpenWest’s $4.80 Per Share Offer from DigitalBridge is Under Investigation (...
GlobeNewswire
13:31
SQUARESPACE ALERT: Squarespace’s $44 Per Share Buyout Offer From Permira is Under Investigation (NYS...
GlobeNewswire
13:30
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwri...
GlobeNewswire
13:30
KANZHUN LIMITED repurchased RMB74 million ordinary shares under its repurchase plan
GlobeNewswire
13:30
Leading Proxy Advisor ISS Recommends Medallion Shareholders Vote “FOR” Both of the Board’s Director ...
GlobeNewswire
13:30
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
GlobeNewswire
13:30
Agrify Corporation Regains Compliance with Nasdaq Stockholders’ Equity Requirement
GlobeNewswire
13:30
TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple ...
GlobeNewswire
13:30
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire
13:30
Clene Provides Update on Its NIH-Funded Expanded Access Program for CNM-Au8® in ALS (ACT-EAP)
GlobeNewswire
13:26
LEGAL DEADLINE ALERT: Sprout Social (Nasdaq: SPT) Investors are Encouraged to Contact BFA Law before...
GlobeNewswire
13:26
CEREVEL THERAPEUTICS ALERT: Cerevel’s $45 Merger Offer From AbbVie is Under Investigation (Nasdaq: C...
GlobeNewswire
13:10
Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page